Indeed, activation of TLR4 and high expression of the TLR4 gene are associated with cholangiocarcinoma (CCA) progression and worse disease outcomes, while lower TLR4 levels are associated with tumor growth suppression [121, 122]. The gene discussed is TLR4; the disease is neoplasm.